GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MultiCell Technologies Inc (OTCPK:MCET) » Definitions » Revenue

MultiCell Technologies (MultiCell Technologies) Revenue : $0.81 Mil (TTM As of Aug. 2015)


View and export this data going back to . Start your Free Trial

What is MultiCell Technologies Revenue?

MultiCell Technologies's revenue for the three months ended in Aug. 2015 was $0.20 Mil. Its revenue for the trailing twelve months (TTM) ended in Aug. 2015 was $0.81 Mil. MultiCell Technologies's Revenue per Share for the three months ended in Aug. 2015 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2015 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


MultiCell Technologies Revenue Historical Data

The historical data trend for MultiCell Technologies's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MultiCell Technologies Revenue Chart

MultiCell Technologies Annual Data
Trend Nov05 Nov06 Nov07 Nov08 Nov09 Nov10 Nov11 Nov12 Nov13 Nov14
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.05 0.05 0.05 0.05

MultiCell Technologies Quarterly Data
Nov10 Feb11 May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.59 0.20

Competitive Comparison of MultiCell Technologies's Revenue

For the Biotechnology subindustry, MultiCell Technologies's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MultiCell Technologies's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MultiCell Technologies's Revenue distribution charts can be found below:

* The bar in red indicates where MultiCell Technologies's Revenue falls into.



MultiCell Technologies Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Aug. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MultiCell Technologies  (OTCPK:MCET) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


MultiCell Technologies Revenue Related Terms

Thank you for viewing the detailed overview of MultiCell Technologies's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


MultiCell Technologies (MultiCell Technologies) Business Description

Traded in Other Exchanges
N/A
Address
68 Cumberland Street, Suite 301, Woonsocket, RI, USA, 02895
MultiCell Technologies Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer and others. Its therapeutic development platform includes several patented techniques used to isolate, characterize and differentiate stem cells from human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor, and MDA-5 signaling. The company's medical device development platform is based on the design of a next-generation bioabsorbable stent, the Ideal BioStent, for interventional cardiology and peripheral vessel applications. All the operations are functioned within United States.
Executives
Stephen Chang director 12912 CAMINO DEL VALLE, POWAY CA 92064
Anthony E Altig director C/O OPTIMER PHARMACEUTICALS, INC, 101 HUDSON STREET, JERSEY CITY NJ 07302
Gregory F Szabo director, officer: President and Treasurer 14505 N. HAYDEN ROAD, #305, SCOTTSDALE AZ 85260

MultiCell Technologies (MultiCell Technologies) Headlines

No Headlines